Comments to: Ranibizumab for persistent diabetic macular edema after bevacizumab treatment

被引：2
|
作者：
Calugaru, Dan [1 ]
Calugaru, Mihai [1 ]
机构：
[1] Univ Med Cluj Napoca, Dept Ophthalmol, Cluj Napoca, Romania
来源：
EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2017年 / 27卷 / 03期
关键词：
D O I：
10.5301/ejo.5000898
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E104 / E105
页数：2
相关论文
共 50 条
  • [1] Ranibizumab for persistent diabetic macular edema after bevacizumab treatment
    Katz, Gabriel
    Moisseiev, Elad
    Goldenberg, Dafna
    Moisseiev, Joseph
    Lomnicky, Yosef
    Abend, Yitzchak
    Treister, Giora
    Levkovitch-Verbin, Hani
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (02) : 210 - 214
  • [2] Author's reply to comments to: Ranibizumab for persistent diabetic macular edema after bevacizumab treatment
    Katz, Gabriel
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (03) : E106 - E106
  • [3] Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment
    Bressler, Susan B.
    Ayala, Allison R.
    Bressler, Neil M.
    Melia, Michele
    Qin, Haijing
    Ferris, Frederick L., III
    Flaxel, Christina J.
    Friedman, Scott M.
    Glassman, Adam R.
    Jampol, Leem.
    Rauser, Michael E.
    JAMA OPHTHALMOLOGY, 2016, 134 (03) : 278 - 285
  • [4] Ranibizumab for the treatment of diabetic macular edema in patients treated with Bevacizumab
    Velez, Gisela
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [5] Comparison of Intravitreal Bevacizumab and Ranibizumab Treatment for Diabetic Macular Edema
    Ozturk, Banu Turgut
    Kerimoglu, Hurkan
    Bozkurt, Banu
    Okudan, Suleyman
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (04) : 373 - 377
  • [6] Efficacy of Ranibizumab in the Treatment of Diabetic Macular Edema Refractory to Bevacizumab
    Sciulli, Harrison
    Miller, David
    Coney, Joseph
    Novak, Michael
    Schartman, Jerome
    Singerman, Lawrence
    Zegarra, Hernando
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [7] Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
    Wells, John A.
    Glassman, Adam R.
    Ayala, Allison R.
    Jampol, Lee M.
    Aiello, Lloyd Paul
    Antoszyk, Andrew N.
    Arnold-Bush, Bambi
    Baker, Carl W.
    Bressler, Neil M.
    Browning, David J.
    Elman, Michael J.
    Ferris, Frederick L.
    Friedman, Scott M.
    Melia, Michele
    Pieramici, Dante J.
    Sun, Jennifer K.
    Beck, Roy W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (13): : 1193 - 1203
  • [8] Variation in the use of bevacizumab and ranibizumab for diabetic macular edema
    Wu, Annie
    Wu, Connie
    Greenberg, Paul B.
    Yu, Fei
    Lum, Flora
    Coleman, Anne
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [9] Ranibizumab 0.3 mg for Persistent Diabetic Macular Edema After Recent, Frequent, and Chronic Bevacizumab: The ROTATE Trial
    Fechter, Chelsea
    Frazier, Heather
    Marcus, William B.
    Farooq, Amina
    Singh, Harinderjit
    Marcus, Dennis M.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2016, 47 (11): : 1 - 18
  • [10] Diabetic Macular Edema Treatment with Bevacizumab vs. Ranibizumab: A Microperimetry Study
    Nepomuceno, Antonio Brunno
    Almeida, Felipe
    Messias, Andre
    Takaki, Erika
    Ribeiro, Jefferson
    Cardillo, Jose
    Scott, Ingrid
    Jorge, Rodrigo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
12345